Glucotrack Appoints Dr. Usman Latif to Clinical Advisory Team

On October 29, 2025, Glucotrack, Inc. announced the appointment of Dr. Usman Latif, MD, MBA, to its clinical advisory team. Dr. Latif, a renowned expert in neuromodulation and Painful Diabetic Neuropathy (PDN), will provide strategic counsel as Glucotrack advances its epidural glucose monitoring applications alongside its continuous blood glucose monitor (CBGM). Dr. Latif's expertise in pain management and product design is expected to be invaluable in developing integrated disease and device management solutions for PDN patients. Glucotrack's technology aims to integrate continuous glucose monitoring into spinal cord stimulation (SCS) devices, potentially simplifying care and improving outcomes for PDN patients. The company has successfully completed a long-term preclinical study demonstrating the feasibility and safety of glucose monitoring in the epidural space.